Semler Scientific Inc (NASDAQ:SMLR) announced its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.01) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.08, Bloomberg Earnings reports.

Shares of Semler Scientific (NASDAQ:SMLR) traded up 5.60% during trading on Tuesday, reaching $6.60. 21,185 shares of the company’s stock traded hands. The company has a 50 day moving average price of $4.83 and a 200 day moving average price of $3.55. The stock’s market capitalization is $36.06 million. Semler Scientific has a 1-year low of $1.28 and a 1-year high of $7.00.

In other Semler Scientific news, Director Herbert J. Semler sold 20,000 shares of Semler Scientific stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $3.37, for a total transaction of $67,400.00. Following the sale, the director now directly owns 130,000 shares in the company, valued at approximately $438,100. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

COPYRIGHT VIOLATION WARNING: This article was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at

Semler Scientific Company Profile

Semler Scientific, Inc develops, manufactures and markets products and services that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The Company markets QuantaFlo and WellChec to its customers. QuantaFlo is an approximately four-minute in-office blood flow test.

Earnings History for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.